Significant anti-fibrotic efficacy of EDP-305, a highly potent and selective farnesoid X receptor (FXR) agonist, in a rat model of thioacetamide-induced liver fibrosis and cirrhosis - Jiang, L BD; Yoon, Y J; Chou, H (2017)
2017, Washington, DC: AASLD Annual Meeting;